The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Leptin Induces Hypertrophy via Endothelin-1–Reactive Oxygen Species Pathway in Cultured Neonatal Rat Cardiomyocytes
Abstract
Background— Obesity is a major risk factor for the development of cardiovascular disease. Emerging evidence indicates that leptin, a protein encoded by the obesity gene, is linked with cardiac hypertrophy in obese humans and directly induces cardiomyocyte hypertrophy in vitro. However, the mechanisms by which leptin induces cardiomyocyte hypertrophy are poorly understood. Methods and Results— This study investigated how leptin contributes to cardiomyocyte hypertrophy. Cultured neonatal rat cardiomyocytes were used to evaluate the effects of leptin on hypertrophy. Both endothelin-1 (ET-1) and reactive oxygen species (ROS) levels were elevated in a concentration-dependent manner in cardiomyocytes treated with leptin for 4 hours compared with those cells without leptin treatment. ET-1 stimulated ROS production in a concentration-dependent manner in cardiomyocytes. The augmentation of ROS levels in cardiomyocytes treated with both leptin and ET-1 was reversed by a selective ET A receptor antagonist, ABT-627, and catalase, a hydrogen peroxide–decomposing enzyme. After treatment for 72 hours, leptin or ET-1 concentration-dependently increased total RNA levels, cell surface areas, and protein synthesis in cardiomyocytes, all of which were significantly inhibited by ABT-627 or catalase treatment. Conclusions— These findings indicate that leptin elevates ET-1 and ROS levels, resulting in hypertrophy of cultured neonatal rat cardiac myocytes. The ET-1–ET A –ROS pathway may be involved in cardiomyocyte hypertrophy induced by leptin. ET A receptor antagonists and antioxidant therapy may provide an effective means of ameliorating cardiac dysfunction in obese humans.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Leptin can also induce generation of reactive oxygen species in the heart (379).”
From Cardiac remodeling in obesity (2008) · cites this paper as [379]
In the citing paper
“Several reports have suggested that leptin directly induced hypertrophy in both human and rodent cardiomyocytes (217, 292, 293, 379).”
From Cardiac remodeling in obesity (2008) · cites this paper as [379]
Citations
Cites
Cardiac Hypertrophy: The Good, the Bad, and the Ugly
Frey, N., & Olson, E. N. (2003) · Annual Review of Physiology · doi:10.1146/annurev.physiol.65.092101.142243 · Cited by 1,480
Keaney, J. F., Larson, M. G., Vasan, R. S., Wilson, P. W. F., Lipinska, I., Corey, D., Massaro, J. M., Sutherland, P., Vita, J. A., & Benjamin, E. J. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000058402.34138.11 · Cited by 1,304
Tartaglia, L. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.10.6093 · Cited by 1,289
Ziccardi, P., Nappo, F., Giugliano, G., Esposito, K., Marfella, R., Cioffi, M., D’Andrea, F., Molinari, A. M., & Giugliano, D. (2002) · Circulation · doi:10.1161/hc0702.104279 · Cited by 994
The cardiac phenotype induced by PPARα overexpression mimics that caused by diabetes mellitus
Finck, B. N., Lehman, J. J., Leone, T. C., Welch, M. J., Bennett, M. J., Kovács, A. D., Han, X., Gross, R. W., Kozak, R., Lopaschuk, G. D., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14080 · Cited by 887
Unger, R. H. (2002) · Annual Review of Medicine · doi:10.1146/annurev.med.53.082901.104057 · Cited by 875
Wallace, A. M., McMahon, A. D., Packard, C. J., Kelly, A., Shepherd, J., Gaw, A., & Sattar, N. A. (2001) · Circulation · doi:10.1161/hc5001.101061 · Cited by 821
Cardiovascular Health in Childhood
Williams, C. L., Hayman, L. L., Daniels, S. R., Robinson, T. N., Steinberger, J., Paridon, S. M., & Bazzarre, T. L. (2002) · Circulation · doi:10.1161/01.cir.0000019555.61092.9e · Cited by 778
The cardiac phenotype induced by PPARα overexpression mimics that caused by diabetes mellitus
Finck, B. N., Lehman, J. J., Leone, T. C., Welch, M. J., Bennett, M. J., Kovács, A., Han, X., Gross, R. W., Kozak, R., Lopaschuk, G. D., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214080 · Cited by 765
Leptin induces oxidative stress in human endothelial cells
Bouloumié, A., Marumo, T., Lafontan, M., & Busse, R. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.10.1231 · Cited by 679
Cited by
Sorted by citations
Items 101–200 of 233
Zheng, J., Ji, F., Yin, Y., Wang, X., Ren, A., Bai, J., Sun, X., Yuan, W., & Li, L. (2010) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2010.05415.x · Cited by 30
The heart in obesity-hypertension
Morse, S. A., Bravo, P. E., Morse, M. C., & Reisin, E. (2005) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.3.4.647 · Cited by 31
Qi, M.-Y., Liu, H.-R., Dai, D., Li, N., & Dai, Y. (2008) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.60.12.0016 · Cited by 30
Adiponectin and Leptin Adipocytokines in Metabolic Syndrome: What Is Its Importance?
Albarracin, M. L. G., & Torres, A. Y. F. (2020) · Dubai Diabetes and Endocrinology Journal · doi:10.1159/000510521 · Cited by 32
Lin, X.-H., Gao, L., Tian, S., Klausen, C., Guo, M., Gao, Q., Liu, M., Wang, H., Wu, D., Zhou, C., et al. (2021) · Scientific Reports · doi:10.1038/s41598-020-79604-4 · Cited by 31
The Sick Adipose Tissue: New Insights Into Defective Signaling and Crosstalk With the Myocardium
Bermúdez, V., Durán, P., Rojas, E., Diaz, M. P., Rivas, J., Nava, M., Chacín, M., de Bravo, M. C., Carrasquero, R., Ponce, C. C., et al. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.735070 · Cited by 31
The mechanisms of vasorelaxant effect of leptin on isolated rabbit aorta
Şahin, A. S., & Barışkaner, H. (2007) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2007.00541.x · Cited by 29
Bigford, G. E., Bracchi-Ricard, V. C., Keane, R. W., Nash, M. S., & Bethea, J. R. (2013) · ASN NEURO · doi:10.1042/an20130021 · Cited by 29
Leptin confers protection against TNF-α-induced apoptosis in rat cardiomyocytes
Lu, Y., Zhao, Y., Xu, S., Jin, C., Wang, M., & Guosheng, F. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.10.134 · Cited by 29
Leptin increases endothelin type A receptor levels in vascular smooth muscle cells
Juan, C., Chuang, T.-Y., Lien, C.-C., Lin, Y.-J., Huang, S., Kwok, C., & Ho, L. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00103.2007 · Cited by 29
Leptin, a mediator of cardiac damage associated with obesity
Martínez‐Martínez, E., Jurado-López, R., Cervantes-Escalera, P., Cachofeiro, V., & Miana, M. (2014) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2013-0060 · Cited by 27
Diabetic Cardiomyopathy: From Mechanism to Management in a Nutshell
Khan, S. M., Ahmad, S. S., & Kamal, M. A. (2020) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530320666200731174724 · Cited by 28
Moringa oleifera offers a Multi-Mechanistic Approach for Management of Obesity in Rats
Ahmed, H. H., Metwally, F. M., Rashad, H. M., Zaazaa, A. M., Ezzat, S. M., & Salama, M. M. (2014) · Cited by 28
Obesity-induced upregulation of myocardial endothelin-1 expression is mediated by leptin
Adiarto, S., Emoto, N., Iwasa, N., & Yokoyama, M. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.12.066 · Cited by 28
Impact of Obesity and Bariatric Surgery on Cardiovascular Disease
Mathier, M. A., & Ramanathan, R. C. (2007) · Medical Clinics of North America · doi:10.1016/j.mcna.2007.02.002 · Cited by 27
Hou, N., Luo, M., Liu, S., Zhang, H., Xiao, Q., Sun, P., Zhang, G., Luo, J., & Chen, M. (2010) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2010.05442.x · Cited by 25
Self-citationTian, X., Zhang, Q., Huang, Y., Chen, S. Y., Tang, C., Sun, Y. K., Du, J., & Jin, H. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/9367673 · Cited by 24
Enhanced hypertrophy in ob/ob mice due to an impairment in expression of atrial natriuretic peptide
Mascareno, E. J., Beckles, D. L., Dhar-Mascareño, M., & Siddiqui, M. A. Q. (2009) · Vascular Pharmacology · doi:10.1016/j.vph.2009.06.005 · Cited by 24
Tagashira, H., Bhuiyan, M. S., Shinoda, Y., Kawahata, K., Numata, T., & Fukunaga, K. (2022) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2022.12.005 · Cited by 23
Ko, S., Chang, S.-S., Lin, I.-H., & Chen, H. (2015) · Biochimie · doi:10.1016/j.biochi.2015.07.019 · Cited by 23
Impact of Weight-Loss Medications on the Cardiovascular System
Drolet, B., Simard, C., & Poirier, P. (2007) · American Journal of Cardiovascular Drugs · doi:10.2165/00129784-200707040-00005 · Cited by 23
Cardiology in contemporary China: An update
Cheng, T. O. (2007) · International Journal of Cardiology · doi:10.1016/j.ijcard.2007.07.030 · Cited by 23
Moey, M., Rajapurohitam, V., Zeidan, A., & Karmazyn, M. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.182600 · Cited by 23
Wojciechowska, C., Jacheć, W., Romuk, E. B., Nowalany-Kozielska, E., Tomasik, A. R., & Siemińśka, L. (2017) · Endokrynologia Polska · doi:10.5603/ep.2017.0005 · Cited by 23
Gómez‐Hurtado, N., Domínguez‐Rodríguez, A., Matéo, P., Fernández‐Velasco, M., Val‐Blasco, A., Aizpún, R., Sabourin, J., Gomez, A. M., Bénitah, J., & Delgado, C. (2017) · The Journal of Physiology · doi:10.1113/jp274030 · Cited by 23
Rajapurohitam, V., Kilić, A., Javadov, S. A., & Karmazyn, M. (2012) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-012-1307-x · Cited by 22
Adiponectin reduces apoptosis of diabetic cardiomyocytes by regulating miR-711/TLR4 axis
Zuo, Y., Xiao, T., Qiu, X., Liu, Z., Zhang, S., & Zhou, N. (2022) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-022-00904-y · Cited by 22
Ko, S., Lin, I.-H., Shieh, T., Ko, H., Chen, H., Chi, T.-C., Chang, S.-S., & Hsu, Y. (2013) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-012-9501-8 · Cited by 22
Li, N., Dai, D., & Dai, Y. (2008) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-008-0309-4 · Cited by 22
Modulation of the cardiovascular system by leptin
Abel, E. D., & Sweeney, G. (2012) · Biochimie · doi:10.1016/j.biochi.2012.03.019 · Cited by 22
Leptin-induced cardiomyocyte hypertrophy is associated with enhanced mitochondrial fission
Jong, C. J., Yeung, J., Tseung, E., & Karmazyn, M. (2018) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-018-3450-5 · Cited by 24
Inhibition of cardiac leptin expression after infarction reduces subsequent dysfunction
Moro, C., Grauzam, S. E., Ormezzano, O., Toufektsian, M.-C., Tanguy, S., Calabrèse, P., Coll, J., Bak, I., Juhász, B., Tósaki, Á., et al. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01154.x · Cited by 21
The role of dietary fatty acids in predicting myocardial structure in fat-fed rats
Jeckel, K. M., Miller, K. E., Chicco, A. J., Chapman, P. L., Mulligan, C. M., Falcone, P. H., Miller, M. L., Pagliassotti, M. J., & Frye, M. A. (2011) · Lipids in Health and Disease · doi:10.1186/1476-511x-10-92 · Cited by 21
Li, N., Jia, N., Dai, D., & Dai, Y. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.06.080 · Cited by 21
Regulation of the ovarian oxidative status by leptin during the ovulatory process in rats
Bilbao, M. G., Yorio, M. P. D., Galarza, R. A., Varone, C. L., & Faletti, A. G. (2015) · Reproduction · doi:10.1530/rep-14-0536 · Cited by 20
Impaired cardiac function in leptin-deficient mice
Ren, J. T., & Ma, H. (2008) · Current Hypertension Reports · doi:10.1007/s11906-008-0084-0 · Cited by 20
Leptin reduces plasma ANP level via nitric oxide-dependent mechanism
Yuan, K., Yu, J., Shah, A., Gao, S., Kim, S., Kim, S. Z., Park, B., & Kim, S. H. (2010) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00598.2009 · Cited by 19
Matsui, H., Yokoyama, T., Tanaka, C., Sunaga, H., Koitabashi, N., Takizawa, T., Arai, M., & Kurabayashi, M. (2012) · BMC Cell Biology · doi:10.1186/1471-2121-13-37 · Cited by 19
Xia, Q.-G., Na, T., Guo, Y., Bi, Y.-T., Zhang, H., & Dai, D. (2007) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2007.00503.x · Cited by 19
Yu, F., Tang, X., Dai, D., & Dai, Y. (2007) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2007.00650.x · Cited by 19
Simvastatin inhibits leptin-induced hypertrophy in cultured neonatal rat cardiomyocytes1
Tai-ping, H. U., Xu, F., Li, Y., & Luo, J. (2006) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2006.00300.x · Cited by 18
Self-citationLiu, Y., Shen, H., Wang, X.-Q.-Y., Liu, H.-Q., Zheng, L., & Luo, J. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26862 · Cited by 20
Self-citationNa, T., Huang, Z., Dai, D., Zhang, Y., & Dai, Y. (2007) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2007.00580.x · Cited by 18
Mushtaq, S., Ali, T., Javed, Q., Tabassum, S., & Murtaza, I. (2015) · PubMed Central · doi:10.22074/cellj.2016.3746 · Cited by 16
Cardiolipin Remodeling in Cardiovascular Diseases: Implication for Mitochondrial Dysfunction
Zhang, H., Yu, F., Tian, Z., & Jia, D. (2025) · Acta Physiologica · doi:10.1111/apha.70073 · Cited by 18
The emerging role of leptin in obesity-associated cardiac fibrosis: evidence and mechanism
Mao, Y., Zhao, K., Li, P., & Sheng, Y. (2022) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-022-04562-6 · Cited by 14
Karmazyn, M., Gan, X. T., & Rajapurohitam, V. (2013) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2013-0057 · Cited by 16
Miao, C. (2011) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2011.05598.x · Cited by 15
Piñeiro, R., Iglesias, M. J., Eirás, S., Viñuela, J. E., Lago, F., & González‐Juanatey, J. R. (2005) · Endocrine Research · doi:10.1080/07435800500456937 · Cited by 13
Redox Control of Growth Factor Signaling: Recent Advances in Cardiovascular Medicine
Suzuki, Y., Nagase, H., Nie, K., & Park, A.-M. (2005) · Antioxidants and Redox Signaling · doi:10.1089/ars.2005.7.829 · Cited by 15
Tóth, M. E., Sárközy, M., Szűcs, G., Dukay, B., Hajdu, P., Zvara, Á., Puskás, L. G., Szebeni, G. J., Ruppert, Z., Csonka, C., et al. (2022) · Biology of Sex Differences · doi:10.1186/s13293-022-00414-6 · Cited by 14
Fat-to-heart crosstalk in health and disease
Lodewijks, F., McKinsey, T. A., & Robinson, E. L. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.990155 · Cited by 13
Left ventricle relative wall thickness and plasma leptin levels
Blasio, A. D., Donato, F., Stefano, A. D., Gallina, S., Granieri, M., Napolitano, G., Petrella, V., Riccardi, I., Santarelli, F., Valentini, P., et al. (2010) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e3181e57813 · Cited by 13
Effect of leptin on peroxidation and antioxidant defense in ethanol‐supplemented Mus musculus heart
Vairappan, B., & Nalini, N. (2007) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2007.00476.x · Cited by 13
PPAR Gamma at the Crossroads of Health and Disease: A Masterchef in Metabolic Homeostasis
Akoum, S. E. (2014) · Endocrinology & Metabolic Syndrome · doi:10.4172/2161-1017.1000126 · Cited by 13
Cheng, Y.-S., Dai, D., & Dai, Y. (2009) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.61.05.0004 · Cited by 13
Liu, Y., Hu, R., Shen, H., Mo, Q., Wang, X.-Q.-Y., Zhang, G., Li, S., Liang, G., Hou, N., & Luo, J. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.60110 · Cited by 12
Self-citationKarmazyn, M., & Gan, X. T. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25021137 · Cited by 12
From Beats to Metabolism: the Heart at the Core of Interorgan Metabolic Cross Talk
Romero-Becerra, R., Santamans, A. M., Arcones, A. C., & Sabio, G. (2023) · Physiology · doi:10.1152/physiol.00018.2023 · Cited by 12
Li, M., Chen, L., Liu, X., Wu, Y., Chen, X., Chen, H., Zhong, Y., & Xu, Y. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117048 · Cited by 11
[Angiotensin II-induced endothelin-1 release in cardiac myocytes].
Villa‐Abrille, M. C., Cingolani, H. E., Garciarena, C. D., Ennis, I. L., & Aiello, E. A. (2006) · PubMed · Cited by 11
Docosahexaenoic Acid Supplementation Does Not Improve Western Diet-Induced Cardiomyopathy in Rats
Jeckel, K. M., Veeramachaneni, D. N. R., Chicco, A. J., Chapman, P. L., Mulligan, C. M., Hegarty, J. R., Pagliassotti, M. J., Ferguson, L. A., Bouma, G. J., & Frye, M. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051994 · Cited by 11
He, H., Liu, Q., Shi, M., Zeng, X., Yang, J. J., Wu, L., & Lian-da, L. (2008) · Phytotherapy Research · doi:10.1002/ptr.2468 · Cited by 11
RetractedYang, D., Xi, J., Xing, Y., Tang, X., Dai, X., Li, K., Li, H., Lv, X., Lu, D., & Wang, H. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.05.133 · Cited by 11
Zhao, Z., Peng, W., Zhou, J., Zhou, Y., Liu, T., Bai, H., Wu, Q., Song, J., Wu, L., Song, X., et al. (2019) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2019.103970 · Cited by 11
Catalase protects cardiomyocytes via its inhibition of nitric oxide synthesis
Chae, H., Ha, K.-C., Kim, D., Cheung, G.-S., Kwak, Y., Kim, H., Kim, Y., Pae, H., Chung, H., Chae, S., et al. (2006) · Nitric Oxide · doi:10.1016/j.niox.2005.11.008 · Cited by 10
Zhang, H., Li, X., Zhou, J., Liu, Y., Jia, Y., & Yuan, Z. (2007) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2007.04716.x · Cited by 10
Macrea, M. M., Martin, T. J., Zăgrean, L., Jia, Z., & Misra, H. P. (2012) · Sleep And Breathing · doi:10.1007/s11325-012-0656-8 · Cited by 10
Fisch, S., Bachner-Hinenzon, N., Ertracht, O., Guo, L., Arad, Y., Ben‐Zvi, D., Liao, R., & Schneiderman, J. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.014761 · Cited by 9
Adipose Tissue Inflammation and Insulin Resistance
Francisco, L., Miriam, H., de Oliveira, A. C., & Alonso‐Vale, M. I. C. (2012) · InTech eBooks · doi:10.5772/53974 · Cited by 9
Cingolani, H. E., Pérez, N. G., Caldiz, C. I., Garciarena, C. D., Giusti, V. C. D., Correa, M. V., Villa‐Abrille, M. C., Yeves, A. M., Ennis, I. L., de Cingolani, G. C., et al. (2009) · Springer eBooks · doi:10.1007/978-90-481-2850-1_13 · Cited by 8
Vasilescu, R., Ifrim, S., & Ionescu-Tirgoviste, C. (2011) · Journal of Diabetes Mellitus · doi:10.4236/jdm.2011.12004 · Cited by 8
Yuan, S., Dai, D., Guan, L., Dai, Y., & Ji, M. (2006) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2006.04488.x · Cited by 8
Leptin Levels are Associated with Subclinical Cardiac Dysfunction in Obese Adolescents
Imerbtham, T., Thitiwuthikiat, P., Jongjitwimol, J., Nuamchit, T., Yingchoncharoen, T., & Siriwittayawan, D. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s245048 · Cited by 7
Tang, X., Qi, M.-Y., Dai, D., & Zhang, C. (2006) · Urology · doi:10.1016/j.urology.2006.03.068 · Cited by 7
El adipocito como órgano endocrino. Implicaciones fisiopatológicas y terapéuticas
Pérez-Mayorga, M. (2007) · Revista Med · Cited by 7
Adipokines disrupt cardiac differentiation and cardiomyocyte survival
Pérez, L. M., de Lucas, B., Bernal, A., & Gálvez, B. G. (2019) · International Journal of Obesity · doi:10.1038/s41366-019-0455-4 · Cited by 6
Semeraro, M. D., Beltrami, A. P., Kharrat, F., Almer, G., Sedej, S., Renner, W., Gruber, H., Curcio, F., & Herrmann, M. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.1080077 · Cited by 6
Transient Mesenteric Ischemia Leads to Remodeling of Rat Mesenteric Resistance Arteries
Caracuel, L., Jiménez‐Altayó, F., Romo, M., Márquez-Martín, A., Dantas, A. P., & Vila, E. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2011.00118 · Cited by 7
Luo, L.-J., Liu, Y., Yuan, X., Zhang, G., Hou, N., Wu, X., Luo, J., & Zhang, G. (2016) · PubMed Central · doi:10.6515/acs20151111a · Cited by 6
Self-citationObesity and Mechanisms of its Negative Impact on the Cardiovascular System
Miklishanskaya, S. V., Solomasova, L. V., & Mazur, M. A. (2020) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2020-02-09 · Cited by 6
Xu, M., Ji, H., Dai, D., Tang, X., & Dai, Y. (2008) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.60.6.0009 · Cited by 5
Wang, X., Zhang, H., Cheng, Y., & Li, X. (2008) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2008.04981.x · Cited by 6
Melaku, L. S., & Nebi, T. D. (2019) · International Journal of Health & Allied Sciences · doi:10.4103/ijhas.ijhas_104_17 · Cited by 6
Ishtiaq, A., Mushtaq, I., Rehman, H., Mushtaq, I., Mushtaq, I., Abbasi, S. W., Liaqat, F., Rasheed, A., Ahmad, S., Akhtar, Z., et al. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.123104 · Cited by 4
Pemberton, C. J. (2007) · Cardiovascular Research · doi:10.1093/cvr/cvm053 · Cited by 5
Sodium-glucose Cotransporter 2 Inhibitors and Pathological Myocardial Hypertrophy
Gao, Z., Bao, J., Hu, Y., Tu, J., Ye, L., & Wang, L. (2023) · Current Drug Targets · doi:10.2174/1389450124666230907115831 · Cited by 4
Karmazyn, M., & Gan, X. T. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms27010003 · Cited by 5
Zhang, X., & Qin, X. (2023) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/172546 · Cited by 4
Weight Loss Drugs and Cardiovascular Risks
Poirier, P. (2010) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-010-0148-y · Cited by 4
Cui, B., Yu, F., Dai, D., Zhang, T., Tang, X., & Dai, Y. (2007) · Drug Development Research · doi:10.1002/ddr.20164 · Cited by 4
Luo, L., Dai, D., & Dai, Y. (2008) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2007.04856.x · Cited by 4
Targeting the Brain Leptin-Melanocortin Pathway to Treat Heart Failure
Omoto, A. C. M., do Carmo, J. M., Mouton, A. J., Wang, Z., Li, X., Spitz, R. W., Hall, J. E., & da Silva, A. A. (2024) · Current Hypertension Reports · doi:10.1007/s11906-024-01318-z · Cited by 4
Wu, T.-J., Wu, D., & Hsu, B. (2023) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2806128 · Cited by 4
Some Features of Correction of Adipose Tissue Dysfunction
Filiniuk, P. Y., Shishkin, A. N., Pchelin, I. Y., Khudyakova, N. V., Воловникова, В. А., & Кулибаба, Т. Г. (2023) · Juvenis scientia · doi:10.32415/jscientia_2023_9_6_6-17 · Cited by 3
Shamim, A., Siddiqui, H. H., Mahmood, T., Bagga, P., & Kumar, R. (2017) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2017.v10i9.18785 · Cited by 3
The actions of leptin on survival and hydrogen peroxide toxicity in primary mixed glial cells of rat
Kabadere, S., Kuş, G., Uyar, R., Öztopçu-Vatan, P., Erkasap, N., Kurt, H., & Güneş, H. V. (2007) · Biologia · doi:10.2478/s11756-007-0148-7 · Cited by 3
Singh, S. K., Tiwari, S., & Agrawal, R. (2024) · Current Bioactive Compounds · doi:10.2174/0115734072322467240816112529 · Cited by 2
Iglesias, P., & Iglesias, I. (2025) · Journal of Endocrinological Investigation · doi:10.1007/s40618-025-02767-2 · Cited by 2
Gaillet, S., La, D., & Rouanet, J. (2012) · InTech eBooks · doi:10.5772/35090 · Cited by 2
Metadata
- Authors
- Xu, F.-P., Chen, M.-S., Wang, Y.-Z., Yi, Q., Lin, S.-B., Chen, A. F., & Luo, J.-D.
- Affiliations
- From the Departments of Pharmacology (F.-P.X., Q.Y., S.-B.L., J.-D.L.) and Internal Medicine (M.-S.C.), Guangzhou Medical College, Guangzhou, China; the Department of Research Laboratory of Pathophysiology, PLA General Hospital, Beijing (Y.-Z.W.), China; and Department of Pharmacology and Toxicology and the Neuroscience Program, Michigan State University, East Lansing, Mich (A.F.C., J.-D.L.). Dr Xu is now at the Department of Pathology, Preclinical Medicine School, Sun Yat-sen University, Guangzhou...
- Sun Yat-sen University (CN)
- ORCID
- Chen, Alex F.
- Venue
- Circulation
- Published
- 2004-09-07
- Volume
- 110
- Issue
- 10
- Pages
- 1269-1275
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2004341742
- Cited by
- 234
- References
- 44
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 6 · 2023: 7 · 2022: 6 · 2021: 8 · 2020: 12 · 2019: 5 · 2018: 6 · 2017: 6 · 2016: 7 · 2015: 9 · 2014: 8 · 2013: 6 · 2012: 13
- FWCI
- 14.92
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Keywords
- leptin, cardiac hypertrophy, endothelin-1, reactive oxygen species, ETA receptor, atrasentan, catalase, neonatal rat cardiomyocytes, obesity, antioxidant therapy, obesity-related cardiovascular disease
- MeSH terms
- Atrasentan, Animals, Animals, Newborn, Antioxidants, Catalase, Cells, Cultured, Gene Expression Regulation, Cardiomegaly, Atrial Natriuretic Factor, Obesity, Pyrrolidines, RNA, Messenger, Rats, Sprague-Dawley, Reactive Oxygen Species, Oxidative Stress, Endothelin-1, Reverse Transcriptase Polymerase Chain Reaction, Leptin, Myocytes, Cardiac, Cell Size, Rats, Endothelin A Receptor Antagonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review